Sarcopenia | Model 1, OR(95%CI), p value | Model 2, OR(95%CI), p value | Model 3, OR(95%CI), p value |
---|---|---|---|
Cognitive impairment | |||
 No | 1.0(Ref) | 1.0(Ref) | 1.0(Ref) |
 Mild | 1.49 (1.16–1.92), .002 | 1.45 (1.12–1.87), .004 | 1.41 (1.10–1.82), .009 |
 Moderate-severe | 3.41 (2.34–4.97),<.001 | 3.27 (2.23–4.79),<.001 | 3.05 (2.08–4.49),<.001 |
Grip strength | |||
 Cognitive impairment | |||
  No | 1.0(Ref) | 1.0(Ref) | 1.0(Ref) |
  Mild | 1.47 (1.19–1.82),<.001 | 1.41 (1.14–1.75), .002 | 1.38 (1.11–1.71), .004 |
  Moderate-severe | 2.24 (1.51–3.32),<.001 | 2.11 (1.42–3.14),<.001 | 2.00 (1.34–2.97), .001 |
Gait speed | |||
 Cognitive impairment | |||
  No | 1.0(Ref) | 1.0(Ref) | 1.0(Ref) |
  Mild | 1.50 (1.22–1.86),<.001 | 1.44 (1.16–1.78), .001 | 1.42 (1.14–1.76), .001 |
  Moderate-severe | 1.76 (1.22–2.56), .003 | 1.66 (1.14–2.42), .008 | 1.60 (1.09–2.33), .016 |
ASMI | |||
 Cognitive impairment | |||
  No | 1.0(Ref) | 1.0(Ref) | 1.0(Ref) |
  Mild | 1.33 (1.05–1.68), .017 | 1.31 (1.04–1.67), .025 | 1.29 (1.02–1.64), .038 |
  Moderat-severe | 2.83 (1.96–4.07),<.001 | 2.74 (1.89–3.96),<.001 | 2.60 (1.79–3.77),<.001 |